Social networks
13,992Activities
Technologies
Entity types
Location
101 South St 6th Floor, Somerville, MA 02143, USA
Somerville
United States of America
Employees
Scale: 51-200
Estimated: 136
Engaged corporates
3Added in Motherbase
9 months agoRewriting the rules of drug creation
Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas including those in metabolic disease, hematology, and immuno-oncology.
Drug Discovery, Drug Development, Single Cell Technologies, AI, Artificial Intelligence, and Machine Learning
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Dia & Co Semiconductors, Retail Apparel and Fashion | Dia & Co Semiconductors, Retail Apparel and Fashion | Other 6 Oct 2024 | | |
Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Oct 2024 | | |
Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Oct 2024 | |